Locate Networks

Locate Bio is a specialist regenerative medicine company focused on developing next-generation orthobiologics to improve the lives of patients with debilitating orthopedic conditions. The company utilizes its proprietary Programmed Release technology platform to create products that provide controlled, site-specific delivery of therapeutic agents, such as proteins and antibiotics. Its lead programs include LDGraft, a recombinant human bone morphogenetic protein-2 (rhBMP-2) bone graft substitute for spinal fusion, and CognitOS, a synthetic bone graft with osteoinductive properties. Locate Bio aims to overcome the limitations of current orthopedic treatments by providing superior bone healing and infection control solutions.